These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 37413883)

  • 1. N-aryltetrahydroisoquinoline derivatives as HA-CD44 interaction inhibitors: Design, synthesis, computational studies, and antitumor effect.
    Espejo-Román JM; Rubio-Ruiz B; Chayah-Ghaddab M; Vega-Gutierrez C; García-García G; Muguruza-Montero A; Domene C; Sánchez-Martín RM; Cruz-López O; Conejo-García A
    Eur J Med Chem; 2023 Oct; 258():115570. PubMed ID: 37413883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective Anticancer Therapy Based on a HA-CD44 Interaction Inhibitor Loaded on Polymeric Nanoparticles.
    Espejo-Román JM; Rubio-Ruiz B; Cano-Cortés V; Cruz-López O; Gonzalez-Resines S; Domene C; Conejo-García A; Sánchez-Martín RM
    Pharmaceutics; 2022 Apr; 14(4):. PubMed ID: 35456622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyaluronic acid conjugated β-cyclodextrin-oligoethylenimine star polymer for CD44-targeted gene delivery.
    Yin H; Zhao F; Zhang D; Li J
    Int J Pharm; 2015 Apr; 483(1-2):169-79. PubMed ID: 25681725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD44 enhances invasion of basal-like breast cancer cells by upregulating serine protease and collagen-degrading enzymatic expression and activity.
    Montgomery N; Hill A; McFarlane S; Neisen J; O'Grady A; Conlon S; Jirstrom K; Kay EW; Waugh DJ
    Breast Cancer Res; 2012 May; 14(3):R84. PubMed ID: 22621373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hyaluronic acid, receptor CD44, and their role in diabetic complications].
    Ievdokimova NIu
    Ukr Biokhim Zh (1999); 2008; 80(5):5-44. PubMed ID: 19248616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Boronic acid-tethered amphiphilic hyaluronic acid derivative-based nanoassemblies for tumor targeting and penetration.
    Jeong JY; Hong EH; Lee SY; Lee JY; Song JH; Ko SH; Shim JS; Choe S; Kim DD; Ko HJ; Cho HJ
    Acta Biomater; 2017 Apr; 53():414-426. PubMed ID: 28216300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. One-pot preparation of hyaluronic acid-coated iron oxide nanoparticles for magnetic hyperthermia therapy and targeting CD44-overexpressing cancer cells.
    Soleymani M; Velashjerdi M; Shaterabadi Z; Barati A
    Carbohydr Polym; 2020 Jun; 237():116130. PubMed ID: 32241421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyaluronic acid/polyethylene glycol nanoparticles for controlled delivery of mitoxantrone.
    Sargazi A; Kamali N; Shiri F; Heidari Majd M
    Artif Cells Nanomed Biotechnol; 2018 May; 46(3):500-509. PubMed ID: 28503952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High molecular weight hyaluronic acid regulates osteoclast formation by inhibiting receptor activator of NF-κB ligand through Rho kinase.
    Ariyoshi W; Okinaga T; Knudson CB; Knudson W; Nishihara T
    Osteoarthritis Cartilage; 2014 Jan; 22(1):111-20. PubMed ID: 24185105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyaluronan-mediated CD44 interaction with RhoGEF and Rho kinase promotes Grb2-associated binder-1 phosphorylation and phosphatidylinositol 3-kinase signaling leading to cytokine (macrophage-colony stimulating factor) production and breast tumor progression.
    Bourguignon LY; Singleton PA; Zhu H; Diedrich F
    J Biol Chem; 2003 Aug; 278(32):29420-34. PubMed ID: 12748184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD44 stimulation by fragmented hyaluronic acid induces upregulation of urokinase-type plasminogen activator and its receptor and subsequently facilitates invasion of human chondrosarcoma cells.
    Kobayashi H; Suzuki M; Kanayama N; Nishida T; Takigawa M; Terao T
    Int J Cancer; 2002 Dec; 102(4):379-89. PubMed ID: 12402308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyaluronan-CD44 interaction promotes c-Src-mediated twist signaling, microRNA-10b expression, and RhoA/RhoC up-regulation, leading to Rho-kinase-associated cytoskeleton activation and breast tumor cell invasion.
    Bourguignon LY; Wong G; Earle C; Krueger K; Spevak CC
    J Biol Chem; 2010 Nov; 285(47):36721-35. PubMed ID: 20843787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and mechanistic insight into enhanced cytotoxic potential of hyaluronic acid conjugated nanoparticles in CD44 overexpressing cancer cells.
    Saneja A; Nayak D; Srinivas M; Kumar A; Khare V; Katoch A; Goswami A; Vishwakarma RA; Sawant SD; Gupta PN
    Eur J Pharm Sci; 2017 Jan; 97():79-91. PubMed ID: 27989859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyaluronan-CD44 interaction promotes c-Jun signaling and miRNA21 expression leading to Bcl-2 expression and chemoresistance in breast cancer cells.
    Chen L; Bourguignon LY
    Mol Cancer; 2014 Mar; 13():52. PubMed ID: 24606718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyaluronan promotes signaling interaction between CD44 and the transforming growth factor beta receptor I in metastatic breast tumor cells.
    Bourguignon LY; Singleton PA; Zhu H; Zhou B
    J Biol Chem; 2002 Oct; 277(42):39703-12. PubMed ID: 12145287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In Silico Design and Selection of New Tetrahydroisoquinoline-Based CD44 Antagonist Candidates.
    Ruiz-Moreno AJ; Reyes-Romero A; Dömling A; Velasco-Velázquez MA
    Molecules; 2021 Mar; 26(7):. PubMed ID: 33810348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD44 interaction with Na+-H+ exchanger (NHE1) creates acidic microenvironments leading to hyaluronidase-2 and cathepsin B activation and breast tumor cell invasion.
    Bourguignon LY; Singleton PA; Diedrich F; Stern R; Gilad E
    J Biol Chem; 2004 Jun; 279(26):26991-7007. PubMed ID: 15090545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyaluronic acid based self-assembling nanosystems for CD44 target mediated siRNA delivery to solid tumors.
    Ganesh S; Iyer AK; Morrissey DV; Amiji MM
    Biomaterials; 2013 Apr; 34(13):3489-502. PubMed ID: 23410679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extravillous trophoblast cell invasion is promoted by the CD44-hyaluronic acid interaction.
    Takahashi H; Takizawa T; Matsubara S; Ohkuchi A; Kuwata T; Usui R; Matsumoto H; Sato Y; Fujiwara H; Okamoto A; Suzuki M; Takizawa T
    Placenta; 2014 Mar; 35(3):163-70. PubMed ID: 24439029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyaluronic-Acid-Tagged Cubosomes Deliver Cytotoxics Specifically to CD44-Positive Cancer Cells.
    Pramanik A; Xu Z; Ingram N; Coletta PL; Millner PA; Tyler AII; Hughes TA
    Mol Pharm; 2022 Dec; 19(12):4601-4611. PubMed ID: 35938983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.